Navigation Links
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Date:12/17/2008

this press release due to the risks and uncertainties inherent in the company's business, including, without limitation: the outcomes of final analyses of data from the company's clinical trials of Acetavance may produce negative or inconclusive results, may differ from the initial analyses, or may be inconsistent with previously conducted clinical trials, and the Food and Drug Administration (FDA) may not agree with Cadence's interpretation of such results; the FDA may require Cadence to complete additional clinical, non-clinical or other requirements prior to the submission or the approval of NDAs for Acetavance; data from clinical trials of Acetavance may demonstrate inadequate therapeutic efficacy, and clinical trial data, as well as reports of adverse events from countries where intravenous acetaminophen is already approved and commercialized, may indicate that the prevalence or severity of adverse side effects is greater than anticipated; the company may experience delays in completing important pre-commercialization manufacturing development activities for Acetavance, and may be required to perform additional pre- clinical or clinical testing prior to submitting, or obtaining approval of, an NDA for this product candidate; the third parties on whom Cadence relies to assist with the development program for Acetavance, including clinical investigators, contract laboratories, clinical research organizations and manufacturing organizations, may not successfully carry out their contractual duties or obligations or meet expected deadlines, and the quality or accuracy of the non-clinical, clinical and manufacturing data generated by such third parties may be of insufficient quality to include in the company's regulatory submissions; Cadence may require substantial additional funding to complete its development program for Acetavance and, if approved, to successfully launch this product candidate, and the company may not be able to raise su
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Adenna, Inc ... 1997, is excited to announce the launch of ... grade gloves made of polyethylene (PE) and approved by ... general applications. , The Enov8 glove might ... sandwiches or mixing salads but our proprietary formula and ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 ProTrailer Network ... Final Cut Pro X . This Effect ... simple and elegantly styled text. , ProTrailer Network ... , ProTrailer Network can easily complement any form of ... and within seconds can make professional looking openers. , ...
(Date:5/26/2015)... IL (PRWEB) May 26, 2015 The ... daily exercise may already be in your pocket. That’s ... has updated its LFconnect mobile app to sync with ... Health, Google Fit and Samsung S-Health – automatically transmitting ... This update, available now for download, empowers the millions ...
(Date:5/26/2015)... Writers and editors can use ... CCMS to make creating, editing, and managing content ... content management system (CCMS) software provider, certified that ... XML Editor Version 17.0, Syncro Soft’s latest software ... merges key editorial functionality of the Vasont CCMS ...
(Date:5/26/2015)... Colorado (PRWEB) May 26, 2015 DENVER ... industry expands and evolves, it is also experiencing many ... And like their mainstream counterparts, one major issue that ... to recycle the tons of paper and plastic that ... , “Where others see waste we see the opportunity ...
Breaking Medicine News(10 mins):Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3
... 8 State,Compensation Insurance Fund is presenting a ... Fund,s Employer Education Series, featuring its own,innovative and ... seminar entitled "Watch Your Back",introduces an educational and ... the very people they are trying to protect ...
... Technologies, Inc.,(Amex: TQ ) ("Cash Tech" or the ... or "AMEX") notified Cash Tech on November 2,2007 that ... continued,listing standards as set forth in part 10 of ... is not in compliance with Section,1003(a)(i) of the Company ...
... progression can now be mapped less to mathematical standards ... study by researchers at Harvard and Johns Hopkins Universities. ... November 9, 2007, provides a new paradigm in calculating ... by mutations in many genes. , Our understanding of ...
... Popper LLP has filed a class,action lawsuit against Medtronic, ... officers and directors in the United States District Court,for ... purchased,Medtronic common stock on the open market from June ... is the first action filed,against Medtronic and alleges claims ...
... of Critical and Fatal Implications of ... Diagnosis of Carbon Monoxide Poisoning, IRVINE, Calif., Nov. ... Motion and Low Perfusion pulse,oximetry, today announced the National ... its members advocating carbon monoxide,screenings for patients presenting with ...
... Cardica, Inc.,(Nasdaq: CRDC ) today announced the ... its common stock for sale by Cardica and,2,579,795 shares ... stockholder, at,a price to the public of $8.50 per ... purchase up to an additional 611,969 shares,of common stock ...
Cached Medicine News:Health News:Free Seminar Presents State Fund's Back Connection(TM), November 13, in Redding 2Health News:Free Seminar Presents State Fund's Back Connection(TM), November 13, in Redding 3Health News:Cash Technologies Discusses AMEX Listing Requirements 2Health News:Cash Technologies Discusses AMEX Listing Requirements 3Health News:Cash Technologies Discusses AMEX Listing Requirements 4Health News:Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT 2Health News:Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT 3Health News:National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning 2Health News:National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning 3Health News:Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock 2Health News:Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock 3
(Date:5/26/2015)... 26, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that the Company,s President and CEO, ... at the Jefferies 2015 Global Healthcare Conference ... a.m. EDT. Dr. Cauwenbergh will present a ...
(Date:5/26/2015)... VANCOUVER, British Columbia , May 26, 2015 ... IMLFF), announced today that it has filed a ... and Trademark Office ("USPTO") relating to the treatment ... of natural cannabinoid compounds developed by InMed. ... Pharmaceuticals, Chief Scientific Officer, commented, "We are excited ...
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... very appreciative of all the hard work that the Minister ... past six months. This program recognizes the needs of the ... at least $75,000 a year, tax free, with annual adjustments ... be eligible for annual payments of $100,000 based on the ...
Breaking Medicine Technology:RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 2RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 3RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference 4InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... Officer, Dr. Ramin Mojdeh, will purchase more than $250,000 in ... Dr. Mojdeh,s initial open market purchase of more than $250,000 ... joined the Company. Dr. Mojdeh will begin making ...
... FALLS, N.J., Aug. 31, 2011 CANTEL MEDICAL CORP. ... A. Krakauer, President & CEO, will be presenting at the ... is scheduled for 11:15 AM EDT on Tuesday, September 13, ... City, with a Q & A session immediately following the ...
Cached Medicine Technology:Unilife COO to Again Purchase More Than $250,000 in Company Shares 2Unilife COO to Again Purchase More Than $250,000 in Company Shares 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: